These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 5497295)
1. [Some biological properties of clinically significant and apparently clinically non-significant strains of Mycobacterium kansasii]. Pollak L; Angulo-Ortega A Pneumonologie; 1970; 142(2):102-7. PubMed ID: 5497295 [No Abstract] [Full Text] [Related]
2. [Mycobacterium kansasii and its variants]. Schröder KH; Magnusson M Zentralbl Bakteriol Orig; 1968; 207(4):498-509. PubMed ID: 5742980 [No Abstract] [Full Text] [Related]
3. Differential identification of Mycobacterium kansasii and Mycobacterium marinum. Silcox VA; David HL Appl Microbiol; 1971 Feb; 21(2):327-34. PubMed ID: 4925535 [TBL] [Abstract][Full Text] [Related]
4. In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands. van Ingen J; van der Laan T; Dekhuijzen R; Boeree M; van Soolingen D Int J Antimicrob Agents; 2010 Feb; 35(2):169-73. PubMed ID: 20006470 [TBL] [Abstract][Full Text] [Related]
5. [Culture and susceptibility testing of mycobacteria with VersaTREK]. Gravet A; Souillard N; Habermacher J; Moser A; Lohmann C; Schmitt F; Delarbre JM Pathol Biol (Paris); 2011 Feb; 59(1):32-8. PubMed ID: 20850229 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria. Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491 [No Abstract] [Full Text] [Related]
8. [Sensitivity of Mycobacterium intracellulare and Mycobacterium kansasii to antituberculous drugs]. Zhao T; Yang SR Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):359-60, 383. PubMed ID: 3582058 [No Abstract] [Full Text] [Related]
9. [The so-called African mycobacteria strains from the tropical West Africa]. Meissner G; Schröder K Zentralbl Bakteriol Orig; 1969; 211(1):69-81. PubMed ID: 4989345 [No Abstract] [Full Text] [Related]
10. Known clinical mycobacterial organisms. Kubica GP Ann N Y Acad Sci; 1970 Oct; 174(2):840-6. PubMed ID: 4925701 [No Abstract] [Full Text] [Related]
11. A possible new pathogen of group iii Mycobacteria. Tsukamura M; Shimoide H; Shaefer WB J Gen Microbiol; 1975 Jun; 88(2):377-80. PubMed ID: 1151342 [No Abstract] [Full Text] [Related]
12. [Mycobacterium xenopei cause of pulmonary diseases and contaminating agent]. Bretey J; Boisvert H Rev Tuberc Pneumol (Paris); 1969; 33(3):337-48. PubMed ID: 5383007 [No Abstract] [Full Text] [Related]
13. [Infections due to rapidly growing mycobacteria]. García-Martos P; García-Agudo L Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):192-200. PubMed ID: 22133415 [TBL] [Abstract][Full Text] [Related]
14. Studies on MOTT bacilli (Mycobacteria other than tubercle bacilli). Byrne J; Conalty ML J Ir Med Assoc; 1970 Mar; 63(393):91-8. PubMed ID: 4190045 [No Abstract] [Full Text] [Related]